Genetic epidemiology of BRCA1 mutations in Norway

被引:37
作者
Moller, P [1 ]
Heimdal, K
Apold, J
Fredriksen, Å
Borg, Å
Hovig, E
Hagen, A
Hagen, B
Pedersen, JC
Mæhle, L
机构
[1] Norwegian Radium Hosp, Dept Canc Genet, Sect Genet Counselling, N-0310 Oslo, Norway
[2] Haukeland Univ Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway
[3] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden
[4] Norwegian Radium Hosp, Dept Tumour Biol, N-0310 Oslo, Norway
[5] Univ Trondheim Hosp, Dept Surg, Trondheim, Norway
[6] Univ Trondheim Hosp, Dept Gynaecol, Trondheim, Norway
[7] Ulleval Univ Hosp, Dept Med Genet, Oslo, Norway
关键词
BCRA1; inherited; breast cancer; ovarian cancer; epidemiology; founder mutation;
D O I
10.1016/S0959-8049(01)00299-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Familial breast-ovarian cancer has been demonstrated to be frequent but unevenly distributed in Norway. This was assumed to be caused by the reduced population size created by the medieval Bubonic plague, 25 generations ago, and by the following rapid expansion. We have previously reported that four mutations account for 68% of the BRCA1 mutation carriers. Subsequent analysis has resulted in a total of 100 separate families carrying one of these founder mutations. The four mutations occurred on one specific BRCA1 haplotype each. The 1675delA, 816delGT and 3347detAG families originated from the South-West coast of Norway with a few Families in the north, while the traceable ancestors of the 1135insA families clustered along the historical inland road from the South-East to mid-Norway. The carriers of each of the four mutations today are descendants of one or a few individuals surviving the plagues. We may identify the majority of BRCA1 mutation carriers in Norway by screening for local founder mutations. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2428 / 2434
页数:7
相关论文
共 27 条
  • [1] Anderson TI, 1996, AM J HUM GENET, V59, P486
  • [2] APOLD J, 1990, AM J HUM GENET, V47, P1002
  • [3] A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland
    Arason, A
    Jonasdottir, A
    Barkardottir, RB
    Bergthorsson, JT
    Teare, MD
    Easton, DF
    Egilsson, V
    [J]. JOURNAL OF MEDICAL GENETICS, 1998, 35 (06) : 446 - 449
  • [4] BROCA P, 1866, TRAITE TUMEURS, P151
  • [5] Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA
    Dorum, A
    Hovig, E
    Tropé, C
    Inganas, M
    Moller, P
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 (05) : 779 - 781
  • [6] A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing
    Dorum, A
    Moller, P
    Kamsteeg, EJ
    Scheffer, H
    Burton, M
    Heimdal, KR
    Mæhle, LO
    Hovig, E
    Tropé, CG
    van der Hout, AH
    van der Meulen, MA
    Buys, CHCM
    Meerman, GJT
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (14) : 2390 - 2392
  • [7] FISHER RA, 1958, GENETICAL THEORY NAT, P83
  • [8] Hakansson S, 1997, AM J HUM GENET, V60, P1068
  • [9] LINKAGE OF EARLY-ONSET FAMILIAL BREAST-CANCER TO CHROMOSOME-17Q21
    HALL, JM
    LEE, MK
    NEWMAN, B
    MORROW, JE
    ANDERSON, LA
    HUEY, B
    KING, MC
    [J]. SCIENCE, 1990, 250 (4988) : 1684 - 1689
  • [10] Costs and benefits of diagnosing familial breast cancer
    Heimdal, K
    Mæhle, L
    Moller, P
    [J]. DISEASE MARKERS, 1999, 15 (1-3) : 167 - 173